“Genome-wide DNA Methylation Analysis Identifies Prognostic CpG Site Markers for Canine Lymphoma Chemotherapy Outcomes”

https://pubmed.ncbi.nlm.nih.gov/38115210

Genome-wide DNA methylation analysis has identified prognostic CpG site markers that can help predict longer survival times in dogs with multicentric high-grade B-cell lymphoma treated with CHOP chemotherapy.